W
WAVEMAN · COMPANY
PHGE · Biomx Inc.
> Ask across nine datasets ⌘K
LIVE
TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475
← ALL COMPANIES

PHGE

BiomX Inc.
PHARMA & BIOTECH · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · CIK 0001739174
ACTIVIST 13D☆ WATCH
INSIDER NET · 180D
-$8.2M
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
5
13F, latest reported quarter
REVENUE GROWTH
-
XBRL, annual
NET MARGIN
-1158.4%
CONVERSIONS · 180D
4
codes C/M, not in net · $3.3M priced
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net -$8.2M over 180 days
-$8.2M of it by a 10%+ holder
below 83% of Pharma & Biotech
CONGRESS
no member of Congress has reported trading it
FUNDS
5 funds added or opened last quarter
below 96% of Pharma & Biotech
REVENUE
no revenue reported in any filing
MARGIN
-1158.4% net margin (latest quarter)
below 90% of Pharma & Biotech
BUYBACKS
no share repurchases reported
SHORT
1.8% of shares outstanding short · 1.0 days to cover · settled 2026-07-31
below 65% of Pharma & Biotech
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
Water IO Ltd. disclosed a 5%+ stake (19.87%) in the last six months.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN -98.6%
-98.6%12M
-99%-62%-24%+13%2025-092025-102025-122026-032026-052026-072026-09 2026-03-17 · Yeganeh Reuven sold $2.6M2026-03-16 · Yeganeh Reuven sold $2.2M2026-03-13 · Yeganeh Reuven sold $1.9M2026-03-12 · Yeganeh Reuven sold $1.5M2026-04-10 · Water IO Ltd. filed a 5%+ stake (19.87%)2026-04-10 · Star 26 Capital Inc. filed a 5%+ stake (19.87%)2026-04-10 · T3 Defense Inc. filed a 5%+ stake (19.87%)2026-04-10 · Menachem Shalom filed a 5%+ stake (19.87%)2026-01-26 · Pyu Pyu Capital, LLC filed a 5%+ stake (19.99%)2026-01-26 · Reuven Yeganeh filed a 5%+ stake (19.99%)
INSIDER SELL13D/G STAKE
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
An activist crossed the 5% line with declared intent.
The record shows a net $8.2M sold by insiders over 180 days, 5 funds added last quarter. Every figure is a federal filing, dated the day it became public.
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, BiomX Inc. insiders sold a net $8.2M of stock across 84 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER
FILED
SHARES
VALUE
Yeganeh Reuven
Director
SELL
2026-03-17
530,000.0
$2.6M
Yeganeh Reuven
Director
SELL
2026-03-16
450,000.0
$2.2M
Yeganeh Reuven
Director
SELL
2026-03-13
370,000.0
$1.9M
Yeganeh Reuven
Director
SELL
2026-03-12
300,000.0
$1.5M
GORDON CARL L
SELL
2024-05-15
24,344.0
$9.3K
84 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 79 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
Nantahala Capital Management, LLC
1,269,990.0 sh
$430.5K
COMMONWEALTH EQUITY SERVICES, LLC
23,414.0 sh
$8.1K
Ikarian Capital, LLC
19,473.0 sh
$6.8K
Kovack Advisors, Inc.
17,200.0 sh
$6.0K
JPMORGAN CHASE & CO
1,538.0 sh
$552
5%+ owners
13D = intent to influence · 13G = passive
Water IO Ltd.
ACTIVIST 13D · 2026-04-10
19.87%
Star 26 Capital Inc.
ACTIVIST 13D · 2026-04-10
19.87%
T3 Defense Inc.
ACTIVIST 13D · 2026-04-10
19.87%
Menachem Shalom
ACTIVIST 13D · 2026-04-10
19.87%
Pyu Pyu Capital, LLC
ACTIVIST 13D · 2026-01-26
19.99%
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Clinical pipeline
ClinicalTrials.gov · 3 registered trials, 1 still enrolling or running — a status change here is dated weeks before the press release
1
Phase 2
1 ACTIVE
2
Multi-phase
0 ACTIVE
TRIALS MATCHED TO THIS TICKER BY SPONSOR NAME · STUDIES RUN UNDER A SUBSIDIARY'S OWN NAME ARE NOT INCLUDED
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
OPERATING INCOME$-41.5M$-44.5M$-25.3M$-27.2M
NET INCOME$-36.2M$-17.7M$-26.2M$-28.3M
EPS (DILUTED)22.1958.315.100.95
OPERATING CASH FLOW$-26.4M$-37.0M$-21.3M$-29.1M
CASH$4.4M$16.9M$14.9M$31.3M
LONG-TERM DEBT$5.4M$10.6M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-06 ALL SYSTEMS LIVE FOR MACHINES →